Roche Holding Stock Forecast for 2022 - 2025 - 2030

Updated on 09/27/2022

Stock Rating
18
Price Target
CHF375.00
Consensus
Outperform
Upside
22.59%
Analysts
10
Stock Rating
18
Upside
22.59%
Analysts
10
Price Target
CHF375.00

Roche Holding Stock Forecast and Price Target

Roche Holding's stock is projected to advance by 22.59% from the previous closing price if it reaches the average target of CHF375.00 by the year's end, as ten reputable analysts recently projected. This potential upside is calculated on a high-end estimate of CHF450.00 and a low-end estimate of CHF300.00. If you're looking for information on Roche Holding stock, consider checking out the forecasts for comparable firms such as NasdaqGS:AMGN.

CHF375.00

22.59% Upside

Outperform
Outperform

Roche Holding Fair Value Forecast for 2022 - 2025 - 2030

Roche Holding's Price has increased by 9.21% In the last three years, going from CHF288.79 to CHF315.38. In the next year, analysts expect Fair Value to reach CHF334.84 – an increase of 6.17%. For the next nine years, the forecast is for Fair Value to grow by 51.11%.

2022 Fair Value Forecast
CHF334.84
2023 Fair Value Forecast
CHF350.82
2024 Fair Value Forecast
CHF366.77
2025 Fair Value Forecast
CHF384.75
2026 Fair Value Forecast
CHF402.15
2027 Fair Value Forecast
CHF420.05
2028 Fair Value Forecast
CHF438.62
2029 Fair Value Forecast
CHF457.36
2030 Fair Value Forecast
CHF476.55
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$307.50 Buy/Sell $333.19 13.82%
ABBV Stock Forecast AbbVie Outperform 9
$141.21 Buy/Sell $164.23 10.47%
DHR Stock Forecast Danaher Outperform 16
$262.66 Buy/Sell $321.60 23.73%
AVGO Stock Forecast Broadcom Buy 17
$462.26 Buy/Sell $701.05 40.61%
ABT Stock Forecast Abbott Laboratories Outperform 14
$99.84 Buy/Sell $128.88 26.20%

Roche Holding Revenue Forecast for 2022 - 2025 - 2030

Roche Holding's Revenue has increased by 10.68% In the last three years, going from CHF59.50B to CHF65.85B. In the next year, analysts expect Revenue to reach CHF70.39B – an increase of 6.89%. For the next nine years, the forecast is for Revenue to grow by 74.21%.

2022 Rev Forecast
CHF70.39B
2023 Rev Forecast
CHF75.19B
2024 Rev Forecast
CHF80.50B
2025 Rev Forecast
CHF85.71B
2026 Rev Forecast
CHF91.16B
2027 Rev Forecast
CHF96.83B
2028 Rev Forecast
CHF102.60B
2029 Rev Forecast
CHF108.57B
2030 Rev Forecast
CHF114.72B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AZN Stock Forecast AstraZeneca PLC Outperform 18
£99.33 Buy/Sell £136.08 43.33%
AMGN Stock Forecast Amgen Hold 9
$226.87 Buy/Sell $246.51 12.40%
GE Stock Forecast General Electric Outperform 17
$64.35 Buy/Sell $94.11 36.75%

Roche Holding Dividend per Share Forecast for 2022 - 2025 - 2030

In the last three years, Roche Holding's Dividend per Share has grown, increasing from CHF8.70 to CHF9.30 – a growth of 6.90%. The next year looks promising for Roche Holding, with analysts predicting Dividend per Share of CHF9.50 – an increase of 2.19%. Over the next nine years, experts anticipate that Roche Holding's Dividend per Share will grow at a rate of 18.84%.

2022 DPS Forecast
CHF9.50
2023 DPS Forecast
CHF9.68
2024 DPS Forecast
CHF9.87
2025 DPS Forecast
CHF10.06
2026 DPS Forecast
CHF10.26
2027 DPS Forecast
CHF10.45
2028 DPS Forecast
CHF10.65
2029 DPS Forecast
CHF10.85
2030 DPS Forecast
CHF11.05
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton, Dickinson and Outperform 17
$231.64 Buy/Sell $278.08 20.88%
MMM Stock Forecast 3M Hold 16
$113.00 Buy/Sell $147.79 21.24%
GSK Stock Forecast GSK Outperform 16
£13.25 Buy/Sell £16.08 43.02%

Roche Holding Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last three years, Roche Holding's Free Cash Flow has grown from CHF15.94B to CHF17.45B – a 9.49% increase. Next year, analysts are expecting Free Cash Flow to reach CHF20.65B – an increase of 18.32%. Over the next nine years, the forecast is for Free Cash Flow to grow by 226.07%.

2022 FCF Forecast
CHF20.65B
2023 FCF Forecast
CHF24.42B
2024 FCF Forecast
CHF28.06B
2025 FCF Forecast
CHF32.17B
2026 FCF Forecast
CHF36.59B
2027 FCF Forecast
CHF41.21B
2028 FCF Forecast
CHF46.16B
2029 FCF Forecast
CHF51.39B
2030 FCF Forecast
CHF56.89B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BSX Stock Forecast Boston Scientific Buy 15
$38.36 Buy/Sell $49.85 25.13%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.00k Buy/Sell ¥0.00 17.65%
BAYN Stock Forecast Bayer Outperform 7
48.37€ Buy/Sell 67.79€ 64.36%

Roche Holding Net Income Forecast for 2022 - 2025 - 2030

In the last three years, Roche Holding's Net Income has grown by 32.67%, from CHF10.50B to CHF13.93B. For the next year, analysts are expecting Net Income to reach CHF15.34B – an increase of 10.13%. Over the next nine years, experts predict that Net Income will grow by 72.54%.

2022 NI Forecast
CHF15.34B
2023 NI Forecast
CHF16.23B
2024 NI Forecast
CHF17.17B
2025 NI Forecast
CHF18.32B
2026 NI Forecast
CHF19.37B
2027 NI Forecast
CHF20.48B
2028 NI Forecast
CHF21.65B
2029 NI Forecast
CHF22.82B
2030 NI Forecast
CHF24.03B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
6501 Stock Forecast Hitachi Buy 18
¥6.30k Buy/Sell ¥0.00 34.06%
CTVA Stock Forecast Corteva Outperform 12
$57.61 Buy/Sell $62.59 21.51%
4519 Stock Forecast Chugai Pharmaceutical Hold 18
¥3.42k Buy/Sell ¥0.00 31.66%

Roche Holding EBITDA Forecast for 2022 - 2025 - 2030

In the last three years, Roche Holding's EBITDA has grown by 7.83%, rising from CHF22.51B to CHF24.27B. For next year, analysts predict EBITDA of CHF25.55B, which would mean an increase of 5.30%. Over the next nine years, experts predict that Roche Holding's EBITDA will grow at a rate of 39.12%.

2022 EBITDA Forecast
CHF25.55B
2023 EBITDA Forecast
CHF26.50B
2024 EBITDA Forecast
CHF27.39B
2025 EBITDA Forecast
CHF28.47B
2026 EBITDA Forecast
CHF29.48B
2027 EBITDA Forecast
CHF30.51B
2028 EBITDA Forecast
CHF31.59B
2029 EBITDA Forecast
CHF32.66B
2030 EBITDA Forecast
CHF33.76B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A Stock Forecast Agilent Technologies Outperform 17
$122.31 Buy/Sell $149.56 22.64%
DXCM Stock Forecast DexCom Buy 16
$80.35 Buy/Sell $120.89 24.46%
ILMN Stock Forecast Illumina Outperform 16
$184.12 Buy/Sell $251.56 30.62%

Roche Holding EBIT Forecast for 2022 - 2025 - 2030

In the last three years, Roche Holding's EBIT has grown by 6.70%, rising from CHF18.92B to CHF20.19B. For next year, analysts predict EBIT of CHF21.48B, which would mean an increase of 6.42%. Over the next nine years, experts predict that Roche Holding's EBIT will grow at a rate of 52.41%.

2022 EBIT Forecast
CHF21.48B
2023 EBIT Forecast
CHF22.57B
2024 EBIT Forecast
CHF23.57B
2025 EBIT Forecast
CHF24.76B
2026 EBIT Forecast
CHF25.90B
2027 EBIT Forecast
CHF27.07B
2028 EBIT Forecast
CHF28.28B
2029 EBIT Forecast
CHF29.51B
2030 EBIT Forecast
CHF30.77B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALC Stock Forecast Alcon Outperform 15
CHF57.42 Buy/Sell CHF0.00 47.44%
DD Stock Forecast DuPont de Nemours Outperform 17
$50.05 Buy/Sell $76.56 47.85%
GMAB Stock Forecast Genmab A/S Outperform 16
kr2.45k Buy/Sell kr2.84k 12.11%

Roche Holding EPS Price Prediction Forecast for 2022 - 2025 - 2030

Roche Holding's EPS has increased by 9.21% In the last three years, going from CHF18.14 to CHF19.81. In the next year, analysts expect EPS to reach CHF21.03 – an increase of 6.17%. For the next nine years, the forecast is for EPS to grow by 51.11%.

2022 EPS Forecast
CHF21.03
2023 EPS Forecast
CHF22.04
2024 EPS Forecast
CHF23.04
2025 EPS Forecast
CHF24.17
2026 EPS Forecast
CHF25.26
2027 EPS Forecast
CHF26.39
2028 EPS Forecast
CHF27.55
2029 EPS Forecast
CHF28.73
2030 EPS Forecast
CHF29.93
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PODD Stock Forecast Insulet Outperform 15
$231.59 Buy/Sell $269.40 20.90%
HOLX Stock Forecast Hologic Outperform 8
$63.66 Buy/Sell $77.18 17.81%
INCY Stock Forecast Incyte Outperform 9
$66.18 Buy/Sell $95.69 35.99%